Vaxcyte, Inc. Common Stock (NASDAQ: PCVX) last traded at $62.62, up 2.09% on the session. The quote above updates while this page is open; the figures below are drawn from Vaxcyte, Inc. Common Stock’s own filings and are restated only when a new one is published.
Vaxcyte, Inc. Common Stock trades on NASDAQ under the ticker PCVX. Its market capitalisation is $9.32 billion.
Valuation measures for Vaxcyte, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.32B |
|---|---|
| Enterprise value | $9.52B |
| Price / book | 3.38 |
| Beta | 0.89 |
Trailing-twelve-month figures tagged in Vaxcyte, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$1.06B |
|---|---|
| EPS (TTM) | -$7.64 |
| Return on equity | -38.59% |
| Cash | $183.19M |
Range and volume for PCVX over the past 52 weeks.
| 52-week high | $65.00 |
|---|---|
| 52-week low | $29.87 |
| Volume | 1.13M |
| Average volume | 1.36M |
| Previous close | $61.34 |
Dividend history for Vaxcyte, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.